BSE filing, NSE: SURYODAY. Summary written from the filing by ALFA Finder's alert engine.
Suryoday Small Finance Bank Ltd: key numbers
- Share price
- ₹133.76
- Market cap
- ₹1,422 Cr
- Revenue (annual)
- ₹2,160 Cr
- Net profit (annual)
- ₹152.0 Cr
- P/E (TTM)
- 7.4×Sector 19.7×
- Promoter holding
- 22.48%+0.00% QoQ
- FII holding
- 4.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suryoday Small Finance Bank Ltd
All →Suryoday Small Finance Bank Debt & Borrowing: ₹100 Cr
Suryoday Small Finance Bank's board approved the issuance of up to Rs. 100 Crore in unsecured, subordinated Lower Tier II Non-Convertible Debentures.
- Value
- ₹100.0 Cr
Suryoday Small Finance Bank Other Announcement
Suryoday Small Finance Bank Ltd filed its quarterly shareholding pattern report. This is a standard regulatory compliance filing under Regulation 31(1)(b).
Suryoday Small Finance Bank Board Meeting Date
Suryoday Small Finance Bank has scheduled a board meeting for October 22, 2026, to consider raising funds through the issuance of Non-Convertible Debentures.
Suryoday Small Finance Bank Regulatory Approval
RBI approved variable pay and fixed remuneration for Suryoday Bank's MD & CEO and Whole-time Director. Shareholders had earlier ratified the package at the 18th AGM.
Suryoday Small Finance Bank Debt & Borrowing: ₹200 Cr
Suryoday Small Finance Bank Limited allotted 200 Basel II compliant unsecured Non-Convertible Debentures (NCDs). The private placement raised Rs. 200 Crore at a 10.05% annual coupon.
- Value
- ₹200.0 Cr
- Execution
- 10 years
Suryoday Small Finance Bank Other Announcement
Suryoday Small Finance Bank has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the period ending September 30, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.